Glucagon-like peptide-1 (GLP-1) type obesity drug craze is hot.Demand for Novo Nordisk's Ozempic, Hugo Bee, and Eli Lilly's ...

Shares of Viking Therapeutics VKTX lost 18% yesterday after pharma giant Merck MRK announced its foray into the obesity space ...

Bio-Path Holdings Inc.’s stock (BPTH) soared over 150% Thursday afternoon, hitting levels last seen in August, making it the ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The level of premature death in the U.S. is still unacceptably high. But progress isn’t just about where you are; it’s also ...

In 2023, 24.3% of US adults had chronic pain, and 8.5% had high-impact chronic pain (HICP) that frequently limited daily ...

The NHS has released an online tool to help patients check if they are eligible for certain weight loss medications - use the ...

A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...

Regardless of age, certain health conditions, such as heart and lung disease, obesity, asthma, diabetes and kidney disease, ...

There are several things you can do to help balance your hormones, including diet and lifestyle adjustments and medications.

The Federal Reserve rolled out its third interest rate cut of 2024 yesterday, a move expected to lower borrowing costs across ...